Humanized anti-CD11d monoclonal antibodies suitable for basic research and therapeutic applications
{{output}}
Background: Immunomodulatory agents targeting the CD11d/CD18 integrin are in development for the treatment of several pathophysiologies including neurotrauma, sepsis, and atherosclerosis. Murine anti-human CD11d therapeutic antib... ...
